A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer.

MLA

Bailey, Howard H., et al. “A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of {alpha}-Difluoromethylornithine in Subjects with Previous History of Skin Cancer.” Cancer Prevention Research (Philadelphia, Pa.), vol. 3, no. 1, Jan. 2010, pp. 35–47. EBSCOhost, https://doi.org/10.1158/1940-6207.CAPR-09-0096.

APA

Bailey, H. H., Kim, K., Verma, A. K., Sielaff, K., Larson, P. O., Snow, S., Lenaghan, T., Viner, J. L., Douglas, J., Dreckschmidt, N. E., Hamielec, M., Pomplun, M., Sharata, H. H., Puchalsky, D., Berg, E. R., Havighurst, T. C., & Carbone, P. P. (2010). A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer. Cancer Prevention Research (Philadelphia, Pa.), 3(1), 35–47. https://doi.org/10.1158/1940-6207.CAPR-09-0096

Chicago

Bailey, Howard H, KyungMann Kim, Ajit K Verma, Karen Sielaff, Paul O Larson, Stephen Snow, Theresa Lenaghan, et al. 2010. “A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of {alpha}-Difluoromethylornithine in Subjects with Previous History of Skin Cancer.” Cancer Prevention Research (Philadelphia, Pa.) 3 (1): 35–47. doi:10.1158/1940-6207.CAPR-09-0096.